Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
April 02, 2025 17:00 ET | Source: Shattuck Labs, Inc. AUSTIN, TX…
Range Impact Announces Major Land Acquisition in West Virginia
CLEVELAND, OHIO, April 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB:…
MEGHAN, DUCHESS OF SUSSEX ANNOUNCES AS EVER’S FIRST COLLECTION WILL BE AVAILABLE FOR PURCHASE TODAY
After much anticipation, As ever's first seasonal drop will be available today…
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ:…
Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410…
Kia Announces March 2025 Global Sales Results
March 2025 global sales of 278,058 units, up 2.2% Y/yOutside of Korea,…
PROFESSIONAL FIGHTERS LEAGUE ANNOUNCES PARTNERSHIP WITH BLOCKCHAIN ANALYTICS LEADER ARKHAM
NEW YORK, April 1, 2025 /PRNewswire/ -- The Professional Fighters League (PFL)…
Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order
March 31, 2025 20:10 ET | Source: Avicanna Inc. Auditor Licensing &…
Blokees Officially Announces the Launch of the second season of 3rd BFC Creation Competition: Breaking the Cocoon Season
SHANGHAI, April 1, 2025 /PRNewswire/ -- On April 1st, the second season…
Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiologys Annual Scientific Session & Expo (ACC.25)
– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and…